
    
      Patients with Type 2 Diabetes, age 35-75y., will be included in this double blind randomized
      placebo controlled study.

      The sample size of 50 patients completing the 30 day study period is based on statistical
      input from Merck Research Laboratories, Rahway NJ.
    
  